Patient-Derived Xenografts: Methods and Protocols 2024 ed. [Kõva köide]

Patient-Derived Xenografts: Historical Evolution, Immunocompromised Host
Models, and Translational Significance.- Patient-Derived Xenograft Models in
Cancer Research: Methodology, Applications, and Future Prospects.-
Patient-Derived Xenografts: A Valuable Preclinical Model for Drug Development
and Biomarker Discovery.- Patient-Derived Xenograft Models for Leukemias.-
Patient-Derived Orthotopic Xenograft Models for High-Grade Pediatric Brain
Cancers.- Generation of Orthotopic and Subcutaneous Patient-Derived Xenograft
Models from Diverse Clinical Tissue Samples of Pediatric Extracranial Solid
Tumors.- Development of Orthotopic Patient-Derived Xenograft Models of
Pediatric Intracranial Tumors.- A Humanized Patient-Derived Xenograft Model
for Pancreatic Cancer.- Development and Expansion of Patient-Derived
Xenografts for Endometrial Cancer.- A Multiplexed Approach to Assess Small
Cell Lung Cancer Subtype Heterogeneity in Primary and Patient-Derived Tumor
Samples.- Generation of Metastatic Cholangiocarcinoma Patient-Derived
Xenograft Models.- Patient-Derived Xenograft Models for Translational
Prostate Cancer Research and Drug Development.- Patient-Derived Xenograft
Models for Ovarian Cancer.- Orthotopic MC-38 Allograft as a Robust
Preclinical Model of Colorectal Carcinoma.- Assessing Protein Expression in
Patient-Derived Xenografts Using Western Blotting.- Analysis of Protein
Interactions in Patient-Derived Xenografts Using Immunoprecipitation.- A
Semi-Automated Proteomics and Phosphoproteomics Protocol for the
Identification of Novel Therapeutic Targets and Predictive Biomarkers in In
Vivo Xenograft Models of Pediatric Cancers.